Wednesday, July 29, 2020

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir The drug, priced at 59 rupees (79 cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.

from Moneycontrol Business News https://ift.tt/2Dfe7Pg

No comments:

Post a Comment

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...